HSBC Holdings
ABMD

HSBC Holdings’s Abiomed Inc ABMD Stock Holding History

HSBC Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,000
Closed -$1.43M – 2908
2019
Q1 		$1.43M Buy
+5,000
New +$1.66M ﹤0.01% 1653

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HSBC Holdings's ABMD Position: Q4 2022 in Review

HSBC Holdings sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 48,162 shares — an estimated $12M sold.

HSBC Holdings first reported a position in ABMD in Q4 2017 and held it in 20 quarters. The position peaked at $42.3M in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • HSBC Holdings reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • HSBC Holdings sold 48,162 Abiomed Inc shares in Q4 2022, an estimated $12M.
  • HSBC Holdings first reported a position in Abiomed Inc in Q4 2017 and held it in 20 quarters.
  • HSBC Holdings's Abiomed Inc position peaked at $42.3M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.